Discover 2020: UTRF Annual Report

UTRF is delighted to share Discover 2020, which celebrates our innovators and UTRF’s impact on innovation, new venture formation, and corporate engagement for the University of Tennessee. Download accessible PDF.   View past annual reports.  … Read More

UTRF Licensee Attralus Secures $25M in Investment

Professor Jonathan Wall and his team at the UT Graduate School of Medicine have spent more than two decades investigating systemic amyloidosis. Their work played an integral role in helping launch the biopharmaceutical company Attralus with technology licensed from UTRF. Today, Attralus announced that it has secured $25 million in investment financing to work on… Read More